FDA Approves Once-Daily HIV Pill Complera
The FDA has approved Gilead's Complera, a combination of the HIV drugs Truvada and Edurant. It's the second complete HIV treatment in a single, once-daily pill. The first, Atripla, was approved in 2006.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
